Raising a Down Round and How to Be Prepared
AGG Talks: Women in Tech Law Podcast - Episode 4: Preparing for a Transaction? What Emerging Growth Companies Need to Know
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 204: Accelerating Life Sciences Startups with James Chappell of SCbio
Welcome to “Lowenstein Africa Presents: Venture Voices”
A Conversation with Janade du Plessis of Launch Africa Ventures: Balancing Sustainable Development with ROI
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 180: SCBIO and the Life Sciences Industry in South Carolina with James Chappell, SCBIO CEO
Podcast Episode 188: The Power of a Sector Based Approach: Specificity Drives Strategy
A Conversation With Consortium - COVID-19 Client Stories
Life Sciences Quarterly: A View From Washington: What to Expect From the SEC
Ryan Hong Discusses Important Contracts for Startups
Venture Capital Trends: East Meets West – Lewis Geffen, Co-chair, Venture Capital Practice
Financing Challenges for Small Cap Companies
Jaffe Sees 'A Lot' of IPOs in 2013 'Pipeline'
JOBS Act Lessens Disclosure Requirements
Our second quarter 2025 corporate venture capital (CVC) survey indicators continue to show challenging market conditions. However, valuations are on the rise in surveyed transactions. In this survey, we track investment...more
Down rounds often make up a natural part of a company's lifecycle and are not as detrimental as some assume. Max Cantor and Samir Bakhru explain the mechanics of down rounds, their impact on capitalization tables and the need...more
As we’ve noted in a previous article, the Y Combinator-hosted SAFE (Simple Agreement for Future Equity) has become the investment contract of choice for startup companies that have already attracted investors. However, the...more
So you decided to use a SAFE (Simple Agreement for Future Equity) to raise money for your new startup – congratulations! And you’re off to a good start because you read our previous article, which summarized how to use the...more
2023 was a pivotal year for the emerging companies, creating new categories of winners and losers across the board. Emerging companies incorporating artificial intelligence or that have clear line of sight to positive cash...more
Whether you’re a first-time founder or a serial entrepreneur, the process of obtaining venture funding can be complicated and confusing. Let’s look at the process of getting a venture financing to closing, and the primary...more
Finance Forum Welcome Remarks - Good afternoon. Welcome to the Cadwalader Finance Forum. I’m Wes Misson, the Co-Chair of the Finance Group at Cadwalader....more
What’s a founder to do? Banks are collapsing; interest rates continue to creep upward; the IPO window remains limited; but growth-stage companies need capital and can only cut costs so much. With continued economic tightness...more
Benjamin Franklin famously cautioned that “an ounce of prevention is worth a pound of cure.” Although Franklin was warning the people of Philadelphia that preventing a fire is better than fighting one, the same admonition...more
Recent events have negatively impacted fintech funding. CB Insights recently published data comparing fintech financing activity in the first quarter 2020 compared to the same quarter in prior years. ...more
Healthcare companies have raised over $37.5 billion globally in the first three quarters of 2019 in over 3,409 private venture funding rounds according to a recent CB Insights report. Compared to full year 2018, the report’s...more
The SEC has proposed amendments to Rule 147 under the Securities Act of 1933, which currently provides a safe harbor for compliance with the Section 3(a)(11) exemption from registration for intrastate securities offerings....more
There have been any number of economic analyses demonstrating that the public markets remain inhospitable to smaller IPOs and blog posts (many, ours) lamenting the absence of smaller IPOs. Recently, in preparing for a...more
Since the adoption of the Jumpstart Our Business Startups (JOBS) Act, emerging companies have a broader array of financing alternatives, including the opportunity to rely on the accommodations available to emerging growth...more
The Finovate conference focuses on FinTech innovations and is structured as a series of 7-minute, individual product demos over two days. More information can be found here. The conference was attended by early stage...more
Spirox has announced it has secured $18.5 million in series B funding. Spirox, based in Menlo Park, Calif., develops minimally invasive technologies to treat nasal obstruction....more
Megan Gates explains the how rules implemented by the SEC and national securities exchanges make raising capital particularly challenging for small-cap companies....more
For many sponsor backed borrowers, and this would include technology companies which have raised at least one round of financing, the equity cure provides a lifeline which isn’t necessarily available to traditional borrowers....more
What a difference a year makes. Last year, we noted that 2013 was a blockbuster year for digital health investments with almost $2 billion of private capital going into the sector. We highlighted the 10 largest deals of 2013,...more